Swedish medtech company Bactiguard receives market authorization in Mexico

Today Bactiguard proudly announce that they have received the market authorisation by the Mexican health authority COFEPRIS. This means that Bactiguard now can enter and commercialize the BIP Foley Catheter product in Mexico.

The distribution partner in Mexico; Grupo Comercial y de Servicios Del Valle (Cervantes group) will now work together with Bactiguard to start up activities to launch the products in order to prevent infections and improve patient safety in Mexico.

“Mexico is a very interesting and fast growing market. Health care associated infections are global, and Mexico is facing the same problem as many other countries. I hope we can make a difference with our unique products for the Mexican people”, says Christian Kinch CEO of Bactiguard.

Health care associated infections (HAI) are the fourth largest cause of death in the world. The Bactiguard coating has been applied to urinary catheters in the U.S. since 1995 and over 125 million Bactiguard coated catheters have been used in clinical practice all over the world.

Press contact:

Linda Nyberg, Vice President International Affairs
Tel: +46 8 440 58 64
linda.nyberg@bactiguard.com
www.bactiguard.com

Bactiguard provides world-leading solutions preventing health care associated infections – the 4th largest cause of death in the western world. By using Bactiguard technology Governments can reduce healthcare cost, lower the use of antibiotics and save lives. The Bactiguard technology consists of an extremely thin noble metal coating that reduces bacterial adhesion and is biocompatible. It can be used on all sorts of medical devices. The Bactiguard® coated urinary catheter has since 1995 been used by more than 125 million patients in the US. Today Bactiguard offers a full range portfolio within infection prevention in the urinary tract, respiratory tract and blood stream.